Increased Expression of AKT3 in Neuroendocrine Differentiated Prostate Cancer Cells Alters the Response Towards Anti-Androgen Treatment

SIMPLE SUMMARY: Metastatic castration-resistant prostate cancer is still untreatable, and patients have a very short life expectancy after diagnosis. One factor that makes metastatic castration-resistant prostate cancer so aggressive and difficult to treat is neuroendocrine differentiation of prosta...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiesehöfer, Marc, Czyrnik, Elena Dilara, Spahn, Martin, Ting, Saskia, Reis, Henning, Dankert, Jaroslaw Thomas, Wennemuth, Gunther
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867287/
https://www.ncbi.nlm.nih.gov/pubmed/33540707
http://dx.doi.org/10.3390/cancers13030578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867287/
https://www.ncbi.nlm.nih.gov/pubmed/33540707
http://dx.doi.org/10.3390/cancers13030578

Ejemplares similares